179 related articles for article (PubMed ID: 27799764)
1. Optimizing superparamagnetic iron oxide nanoparticles as drug carriers using an in vitro blood-brain barrier model.
Shi D; Mi G; Bhattacharya S; Nayar S; Webster TJ
Int J Nanomedicine; 2016; 11():5371-5379. PubMed ID: 27799764
[TBL] [Abstract][Full Text] [Related]
2. Controlling ferrofluid permeability across the blood–brain barrier model.
Shi D; Sun L; Mi G; Sheikh L; Bhattacharya S; Nayar S; Webster TJ
Nanotechnology; 2014 Feb; 25(7):075101. PubMed ID: 24457539
[TBL] [Abstract][Full Text] [Related]
3. Comparison study of ferrofluid and powder iron oxide nanoparticle permeability across the blood-brain barrier.
Hoff D; Sheikh L; Bhattacharya S; Nayar S; Webster TJ
Int J Nanomedicine; 2013; 8():703-10. PubMed ID: 23426527
[TBL] [Abstract][Full Text] [Related]
4. Uptake and transport of superparamagnetic iron oxide nanoparticles through human brain capillary endothelial cells.
Thomsen LB; Linemann T; Pondman KM; Lichota J; Kim KS; Pieters RJ; Visser GM; Moos T
ACS Chem Neurosci; 2013 Oct; 4(10):1352-60. PubMed ID: 23919894
[TBL] [Abstract][Full Text] [Related]
5. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.
Lu W; Tan YZ; Hu KL; Jiang XG
Int J Pharm; 2005 May; 295(1-2):247-60. PubMed ID: 15848009
[TBL] [Abstract][Full Text] [Related]
6. Superparamagnetic iron-oxide nanoparticles mPEG350- and mPEG2000-coated: cell uptake and biocompatibility evaluation.
Silva AH; Lima E; Mansilla MV; Zysler RD; Troiani H; Pisciotti MLM; Locatelli C; Benech JC; Oddone N; Zoldan VC; Winter E; Pasa AA; Creczynski-Pasa TB
Nanomedicine; 2016 May; 12(4):909-919. PubMed ID: 26767515
[TBL] [Abstract][Full Text] [Related]
7. Superparamagnetic Iron Oxide Nanoparticles Modified with Tween 80 Pass through the Intact Blood-Brain Barrier in Rats under Magnetic Field.
Huang Y; Zhang B; Xie S; Yang B; Xu Q; Tan J
ACS Appl Mater Interfaces; 2016 May; 8(18):11336-41. PubMed ID: 27092793
[TBL] [Abstract][Full Text] [Related]
8. Bio-identity and fate of albumin-coated SPIONs evaluated in cells and by the C. elegans model.
Yu SM; Gonzalez-Moragas L; Milla M; Kolovou A; Santarella-Mellwig R; Schwab Y; Laromaine A; Roig A
Acta Biomater; 2016 Oct; 43():348-357. PubMed ID: 27427227
[TBL] [Abstract][Full Text] [Related]
9. Organization of Endothelial Cells, Pericytes, and Astrocytes into a 3D Microfluidic in Vitro Model of the Blood-Brain Barrier.
Wang JD; Khafagy el-S; Khanafer K; Takayama S; ElSayed ME
Mol Pharm; 2016 Mar; 13(3):895-906. PubMed ID: 26751280
[TBL] [Abstract][Full Text] [Related]
10. Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphoma.
Saesoo S; Sathornsumetee S; Anekwiang P; Treetidnipa C; Thuwajit P; Bunthot S; Maneeprakorn W; Maurizi L; Hofmann H; Rungsardthong RU; Saengkrit N
Colloids Surf B Biointerfaces; 2018 Jan; 161():497-507. PubMed ID: 29128836
[TBL] [Abstract][Full Text] [Related]
11. The combined magnetic field and iron oxide-PLGA composite particles: Effective protein antigen delivery and immune stimulation in dendritic cells.
Saengruengrit C; Ritprajak P; Wanichwecharungruang S; Sharma A; Salvan G; Zahn DRT; Insin N
J Colloid Interface Sci; 2018 Jun; 520():101-111. PubMed ID: 29529457
[TBL] [Abstract][Full Text] [Related]
12. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.
Wahajuddin ; Arora S
Int J Nanomedicine; 2012; 7():3445-71. PubMed ID: 22848170
[TBL] [Abstract][Full Text] [Related]
13. [Effect of lysophosphatidic acid increase the permeability of blood-brain barrier model].
Gan N; Yin F; Peng J; Wang WD
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):416-8. PubMed ID: 18581898
[TBL] [Abstract][Full Text] [Related]
14. Promoting the Delivery of Nanoparticles to Atherosclerotic Plaques by DNA Coating.
Zhang L; Tian XY; Chan CKW; Bai Q; Cheng CK; Chen FM; Cheung MSH; Yin B; Yang H; Yung WY; Chen Z; Ding F; Leung KC; Zhang C; Huang Y; Lau JYW; Choi CHJ
ACS Appl Mater Interfaces; 2019 Apr; 11(15):13888-13904. PubMed ID: 30516979
[TBL] [Abstract][Full Text] [Related]
15. Amino-polyvinyl alcohol coated superparamagnetic iron oxide nanoparticles are suitable for monitoring of human mesenchymal stromal cells in vivo.
Schulze F; Dienelt A; Geissler S; Zaslansky P; Schoon J; Henzler K; Guttmann P; Gramoun A; Crowe LA; Maurizi L; Vallée JP; Hofmann H; Duda GN; Ode A
Small; 2014 Nov; 10(21):4340-51. PubMed ID: 24990430
[TBL] [Abstract][Full Text] [Related]
16. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
[TBL] [Abstract][Full Text] [Related]
17. Establishment of coculture model of blood-brain barrier in vitro for nanoparticle's transcytosis and toxicity evaluation.
Lu W; Tan YZ; Jiang XG
Yao Xue Xue Bao; 2006 Apr; 41(4):296-304. PubMed ID: 16856472
[TBL] [Abstract][Full Text] [Related]
18. Quaternary ammonium beta-cyclodextrin nanoparticles for enhancing doxorubicin permeability across the in vitro blood-brain barrier.
Gil ES; Li J; Xiao H; Lowe TL
Biomacromolecules; 2009 Mar; 10(3):505-16. PubMed ID: 19216528
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging of post-ischemic blood-brain barrier damage with PEGylated iron oxide nanoparticles.
Liu DF; Qian C; An YL; Chang D; Ju SH; Teng GJ
Nanoscale; 2014 Dec; 6(24):15161-7. PubMed ID: 25374303
[TBL] [Abstract][Full Text] [Related]
20. Cellular interactions of functionalized superparamagnetic iron oxide nanoparticles on oligodendrocytes without detrimental side effects: Cell death induction, oxidative stress and inflammation.
Sruthi S; Maurizi L; Nury T; Sallem F; Boudon J; Riedinger JM; Millot N; Bouyer F; Lizard G
Colloids Surf B Biointerfaces; 2018 Oct; 170():454-462. PubMed ID: 29958160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
